Abstract

Objective: Although a body of evidence indicates a link between psychiatric illnesses and allergies, no one has investigated the association between schizophrenia and atopic disorders. The objective of this nationwide population-based study was to examine the prevalence and risk of atopic disorders (asthma, allergic rhinitis, urticaria, and atopic dermatitis) among schizophrenia patients. Method: This study used data from the Taiwan National Health Insurance Research Database covering the years 2000 to 2002. A total of 44,187 patients diagnosed with schizophrenia in the year 2000 were included, together with 132,561 matched non-psychiatric controls. Follow up until the end of 2002 identified concurrent diagnoses of atopic disorders. Logistic regression analyses were performed after controlling for the covariates of socio-demographic characteristics. Results: Findings indicated high comorbidity, with 20.2% of schizophrenia patients (approximately one in five) experiencing concurrent atopic disorders. Moreover, schizophrenia in patients was independently associated with a 1.3-fold increased risk (95%CI = 1.24-1.39) of concurrent asthma, after adjusting for socio-demographic characteristics. Yet the risk of diagnosed allergic rhinitis and urticaria was 23% (95%CI = 0.74-0.81) and 26% (95%CI = 0.72-0.77) lower, respectively, among schizophrenia patients compared to people without any psychiatric disease. Conclusion: Data suggests an increased risk of asthma and decreased risk of allergic rhinitis and urticaria among schizophrenia patients. Future studies on the identification of common etiologic pathways for schizophrenia and asthma could be significant for developing innovative treatments that target both illnesses concurrently.

Original languageEnglish
Pages (from-to)191-196
Number of pages6
JournalSchizophrenia Research
Volume108
Issue number1-3
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Schizophrenia
Population
Urticaria
Asthma
Psychiatry
Demography
National Health Programs
Atopic Dermatitis
Taiwan
Comorbidity
Hypersensitivity
Logistic Models
Regression Analysis
Databases
Research
Allergic Rhinitis

Keywords

  • Asthma
  • Atopic disorder
  • Rhinitis
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

@article{b19994ca33814812a060887237188fe2,
title = "Prevalence and risk of atopic disorders among schizophrenia patients: A nationwide population based study",
abstract = "Objective: Although a body of evidence indicates a link between psychiatric illnesses and allergies, no one has investigated the association between schizophrenia and atopic disorders. The objective of this nationwide population-based study was to examine the prevalence and risk of atopic disorders (asthma, allergic rhinitis, urticaria, and atopic dermatitis) among schizophrenia patients. Method: This study used data from the Taiwan National Health Insurance Research Database covering the years 2000 to 2002. A total of 44,187 patients diagnosed with schizophrenia in the year 2000 were included, together with 132,561 matched non-psychiatric controls. Follow up until the end of 2002 identified concurrent diagnoses of atopic disorders. Logistic regression analyses were performed after controlling for the covariates of socio-demographic characteristics. Results: Findings indicated high comorbidity, with 20.2{\%} of schizophrenia patients (approximately one in five) experiencing concurrent atopic disorders. Moreover, schizophrenia in patients was independently associated with a 1.3-fold increased risk (95{\%}CI = 1.24-1.39) of concurrent asthma, after adjusting for socio-demographic characteristics. Yet the risk of diagnosed allergic rhinitis and urticaria was 23{\%} (95{\%}CI = 0.74-0.81) and 26{\%} (95{\%}CI = 0.72-0.77) lower, respectively, among schizophrenia patients compared to people without any psychiatric disease. Conclusion: Data suggests an increased risk of asthma and decreased risk of allergic rhinitis and urticaria among schizophrenia patients. Future studies on the identification of common etiologic pathways for schizophrenia and asthma could be significant for developing innovative treatments that target both illnesses concurrently.",
keywords = "Asthma, Atopic disorder, Rhinitis, Schizophrenia",
author = "Chen, {Yi Hua} and Lee, {Hsin Chien} and Lin, {Herng Ching}",
year = "2009",
month = "3",
doi = "10.1016/j.schres.2008.12.021",
language = "English",
volume = "108",
pages = "191--196",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Prevalence and risk of atopic disorders among schizophrenia patients

T2 - A nationwide population based study

AU - Chen, Yi Hua

AU - Lee, Hsin Chien

AU - Lin, Herng Ching

PY - 2009/3

Y1 - 2009/3

N2 - Objective: Although a body of evidence indicates a link between psychiatric illnesses and allergies, no one has investigated the association between schizophrenia and atopic disorders. The objective of this nationwide population-based study was to examine the prevalence and risk of atopic disorders (asthma, allergic rhinitis, urticaria, and atopic dermatitis) among schizophrenia patients. Method: This study used data from the Taiwan National Health Insurance Research Database covering the years 2000 to 2002. A total of 44,187 patients diagnosed with schizophrenia in the year 2000 were included, together with 132,561 matched non-psychiatric controls. Follow up until the end of 2002 identified concurrent diagnoses of atopic disorders. Logistic regression analyses were performed after controlling for the covariates of socio-demographic characteristics. Results: Findings indicated high comorbidity, with 20.2% of schizophrenia patients (approximately one in five) experiencing concurrent atopic disorders. Moreover, schizophrenia in patients was independently associated with a 1.3-fold increased risk (95%CI = 1.24-1.39) of concurrent asthma, after adjusting for socio-demographic characteristics. Yet the risk of diagnosed allergic rhinitis and urticaria was 23% (95%CI = 0.74-0.81) and 26% (95%CI = 0.72-0.77) lower, respectively, among schizophrenia patients compared to people without any psychiatric disease. Conclusion: Data suggests an increased risk of asthma and decreased risk of allergic rhinitis and urticaria among schizophrenia patients. Future studies on the identification of common etiologic pathways for schizophrenia and asthma could be significant for developing innovative treatments that target both illnesses concurrently.

AB - Objective: Although a body of evidence indicates a link between psychiatric illnesses and allergies, no one has investigated the association between schizophrenia and atopic disorders. The objective of this nationwide population-based study was to examine the prevalence and risk of atopic disorders (asthma, allergic rhinitis, urticaria, and atopic dermatitis) among schizophrenia patients. Method: This study used data from the Taiwan National Health Insurance Research Database covering the years 2000 to 2002. A total of 44,187 patients diagnosed with schizophrenia in the year 2000 were included, together with 132,561 matched non-psychiatric controls. Follow up until the end of 2002 identified concurrent diagnoses of atopic disorders. Logistic regression analyses were performed after controlling for the covariates of socio-demographic characteristics. Results: Findings indicated high comorbidity, with 20.2% of schizophrenia patients (approximately one in five) experiencing concurrent atopic disorders. Moreover, schizophrenia in patients was independently associated with a 1.3-fold increased risk (95%CI = 1.24-1.39) of concurrent asthma, after adjusting for socio-demographic characteristics. Yet the risk of diagnosed allergic rhinitis and urticaria was 23% (95%CI = 0.74-0.81) and 26% (95%CI = 0.72-0.77) lower, respectively, among schizophrenia patients compared to people without any psychiatric disease. Conclusion: Data suggests an increased risk of asthma and decreased risk of allergic rhinitis and urticaria among schizophrenia patients. Future studies on the identification of common etiologic pathways for schizophrenia and asthma could be significant for developing innovative treatments that target both illnesses concurrently.

KW - Asthma

KW - Atopic disorder

KW - Rhinitis

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=60249100243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60249100243&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2008.12.021

DO - 10.1016/j.schres.2008.12.021

M3 - Article

C2 - 19171465

AN - SCOPUS:60249100243

VL - 108

SP - 191

EP - 196

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -